Raffles Medical Group Ltd (SGX:BSL)
Singapore · Delayed Price · Currency is SGD 1.030
+0.020 (1.98%)
Aug 6, 2025, 5:07 PM SGT
BM Technologies Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 63.71 | 62.24 | 90.15 | 143.21 | 84.17 | 65.89 | Upgrade |
Depreciation & Amortization | 41.62 | 40.75 | 35.98 | 37.88 | 37.1 | 35.5 | Upgrade |
Other Amortization | 3.65 | 2.33 | 2.27 | 2.34 | 2.23 | - | Upgrade |
Loss (Gain) From Sale of Assets | 1.92 | 1.92 | -0.35 | -0.02 | 0.06 | 0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 2.91 | 3.09 | -7.24 | 19.15 | 4.64 | 9.63 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0 | Upgrade |
Stock-Based Compensation | 3.25 | 3.47 | 3.41 | 3.16 | 2.47 | 1.62 | Upgrade |
Other Operating Activities | -5.27 | -6.31 | -23.82 | 23 | 15.27 | 12.81 | Upgrade |
Change in Accounts Receivable | 2.9 | -28.1 | 95.35 | -32.62 | -48.33 | -30.3 | Upgrade |
Change in Inventory | 0.23 | 1.7 | 0.63 | 0.28 | 1.21 | -4.34 | Upgrade |
Change in Accounts Payable | -8.21 | -1.54 | -37.34 | -6.23 | 61.11 | 37.84 | Upgrade |
Change in Unearned Revenue | 1.58 | 6.69 | 30.27 | 6.08 | - | - | Upgrade |
Change in Other Net Operating Assets | - | - | - | - | 0.17 | 4.51 | Upgrade |
Operating Cash Flow | 108.29 | 86.25 | 189.31 | 196.23 | 160.11 | 133.15 | Upgrade |
Operating Cash Flow Growth | 11.42% | -54.44% | -3.52% | 22.55% | 20.25% | 19.79% | Upgrade |
Capital Expenditures | -10.44 | -19.27 | -20.53 | -25.01 | -49.94 | -58.88 | Upgrade |
Sale of Property, Plant & Equipment | 0 | 1.09 | 0.52 | 0.16 | 0.05 | 0.01 | Upgrade |
Sale (Purchase) of Intangibles | -2.21 | -1.64 | -1.41 | -0.29 | -2.86 | -1.19 | Upgrade |
Sale (Purchase) of Real Estate | - | - | - | - | -0.07 | -3.41 | Upgrade |
Investment in Securities | - | - | - | - | - | 0.01 | Upgrade |
Other Investing Activities | 9.25 | 9.95 | 9.01 | 2.31 | 0.63 | 1.27 | Upgrade |
Investing Cash Flow | -3.4 | -9.87 | -12.41 | -22.83 | -52.2 | -62.19 | Upgrade |
Long-Term Debt Issued | - | 67.67 | 110.94 | 85.61 | 47.01 | 70.51 | Upgrade |
Total Debt Issued | 14.81 | 67.67 | 110.94 | 85.61 | 47.01 | 70.51 | Upgrade |
Long-Term Debt Repaid | - | -92.98 | -122.41 | -192.19 | -51.6 | -66.95 | Upgrade |
Net Debt Issued (Repaid) | -27.65 | -25.31 | -11.47 | -106.58 | -4.58 | 3.56 | Upgrade |
Issuance of Common Stock | 0.45 | 0.28 | 7.44 | 6.03 | 5.6 | 0.78 | Upgrade |
Repurchase of Common Stock | -7.52 | - | -5.7 | -24.34 | -3.23 | - | Upgrade |
Common Dividends Paid | -46.27 | -44.58 | -70.68 | -52.02 | -37.35 | -19.19 | Upgrade |
Other Financing Activities | -4.59 | -6.6 | -5.12 | -6.8 | -7.31 | -6.03 | Upgrade |
Financing Cash Flow | -85.58 | -76.2 | -85.52 | -183.7 | -46.87 | -20.88 | Upgrade |
Foreign Exchange Rate Adjustments | -1.39 | 0.95 | -0.89 | -1.55 | 0.81 | 1.23 | Upgrade |
Net Cash Flow | 17.92 | 1.13 | 90.49 | -11.85 | 61.85 | 51.31 | Upgrade |
Free Cash Flow | 97.85 | 66.98 | 168.79 | 171.21 | 110.17 | 74.27 | Upgrade |
Free Cash Flow Growth | 31.42% | -60.31% | -1.42% | 55.40% | 48.34% | 393.22% | Upgrade |
Free Cash Flow Margin | 12.79% | 8.90% | 23.84% | 20.75% | 15.19% | 13.07% | Upgrade |
Free Cash Flow Per Share | 0.05 | 0.04 | 0.09 | 0.09 | 0.06 | 0.04 | Upgrade |
Cash Interest Paid | 4.59 | 5.03 | 5.12 | 6.8 | 7.31 | 6.03 | Upgrade |
Cash Income Tax Paid | - | 1.16 | 21.14 | 29.15 | 21.74 | 9.71 | Upgrade |
Levered Free Cash Flow | 68.62 | 57.6 | 193.49 | 113.84 | 82.13 | 25.71 | Upgrade |
Unlevered Free Cash Flow | 71.59 | 61.21 | 197.29 | 118.13 | 86.11 | 28.93 | Upgrade |
Change in Net Working Capital | 17.67 | 17.61 | -109.96 | 33.24 | -23.24 | -7.47 | Upgrade |
Updated Feb 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.